Chemiluminescence Imaging plays an important role in several scientific fields including biochemistry, molecular biology, genetics, and clinical diagnosis by providing fast, sensitive and low-cost protein and nucleic acid quantification. It uses light-producing chemical reactions for its detection and analysis. Some key advantages of Chemiluminescence Imaging are its high sensitivity, low background signal, wide dynamic range, and real-time detection capabilities without any need for radioactive isotopes.
The global Chemiluminescence Imaging market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The growing need for low-cost protein and nucleic acid quantification across various end-use industries like healthcare, biomedical research, and clinical diagnostics is expected to drive the demand for Chemiluminescence Imaging during the forecast period. Due to its wider dynamic range and quantitative detection capabilities, Chemiluminescence Imaging allows faster and more cost-effective protein and nucleic acid analysis compared to traditional technologies like fluorescence. This is encouraging various small and mid-sized laboratories and research institutes to adopt Chemiluminescence Imaging over other alternatives, thereby offering significant growth opportunities for players in this market. Porter's Analysis Threat of new entrants: Low economies of scale in R&D and manufacturing pose barriers for new entrants in the chemiluminescence imaging market. Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes. Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated products and technologies involved. Threat of new substitutes: Substitutes like fluorescence imaging pose low-to-moderate threat due to advantages of chemiluminescence imaging in sensitivity. Competitive rivalry: Intense competition exists among existing players to gain market share through innovations and expansions. SWOT Analysis Strengths: Sensitivity, less background signal and use of non-radioactive substrates. Weaknesses: High cost of instruments, need for specialized equipment and skilled professionals for operation. Opportunities: Increasing research activities in biotechnology and life sciences. Untapped markets in developing nations. Threats: Growth of alternative techniques, stringent safety regulations. Key Takeaways The Global chemiluminescence imaging market Size is estimated to be valued at US$ 13.2 billion in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030. North America dominates the market currently due to heavy investments in research and presence of advanced medical and research facilities. Asia Pacific is expected to grow at the fastest rate owing to increasing research spending and expansion of key players in the region. Key players operating in the chemiluminescence imaging market are Azure Biosystems, Inc.,Berthold Technologies GmbH & Co. KG,Carestream Health, Inc.,GE Healthcare,LI-COR Biosciences,PerkinElmer, Inc.,Syngene International Limited,Tecan Trading AG,Thermo Fisher Scientific Inc.,UVItec Limited. Get More Insights On This Topic: https://www.newswirestats.com/chemiluminescence-imaging-market-forecast-outlook-trend-2023-2030/
0 Comments
Leave a Reply. |
AuthorCOHERENT MARKET INSIGHTS |